CBIZ REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 RESULTS
For the 2021 fourth quarter, CBIZ recorded revenue of
For the full year ended
As previously announced on
As previously announced on
Reconciliations for adjusted diluted EPS and adjusted EBITDA to the most directly comparable GAAP measures can be found in the tables of this release.
For the full year ended
"2021 also proved to be an important year for our strategic acquisition activity as we capitalized on a full and expanding pipeline of opportunities starting early in the year," Grisko continued. "We closed six acquisitions adding approximately
"Coming off such a strong year, and with the completion of our latest acquisition, we expect another year of solid growth in 2022," Grisko concluded.
2022 Outlook
- The Company expects revenue to grow within a range of 19% to 21% over the prior year.
- Although a number of factors may impact the tax rate, the Company expects an effective tax rate of approximately 25%.
- The Company expects a weighted average fully diluted share count of approximately 53.0 to 53.5 million shares.
- The Company expects GAAP fully diluted earnings per share from continuing operations to grow within a range of 43% to 46%, to
$1.89 to$1.93 per share over the$1.32 per share reported for 2021. - The Company expects adjusted fully diluted earnings per share from continuing operations to grow within a range of 20% to 22%, to
$1.99 to$2.03 per share over the adjusted$1.66 per share reported for 2021.
Conference Call
CBIZ will host a conference call at
About CBIZ
CBIZ is a leading provider of financial, insurance and advisory services to businesses throughout
Forward-Looking Statements
Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to, the impact of COVID-19 on the Company's business and operations and those of our clients; the Company's ability to adequately manage and sustain its growth; the Company's dependence on the current trend of outsourcing business services; the Company's dependence on the services of its CEO and other key employees; competitive pricing pressures; general business and economic conditions; and changes in governmental regulation and tax laws affecting the Company's insurance business or its business services operations. A more detailed description of such risks and uncertainties may be found in the Company's filings with the
FINANCIAL HIGHLIGHTS (UNAUDITED) THREE MONTHS ENDED (In thousands, except percentages and per share data)
|
||||||||
Three Months Ended |
||||||||
2021 |
% |
2020 |
% |
|||||
Revenue |
|
100.0% |
|
100.0% |
||||
Operating expenses (1) |
246,402 |
101.5 |
211,748 |
100.3 |
||||
Gross loss |
(3,574) |
(1.5) |
(638) |
(0.3) |
||||
Corporate general and administrative expenses (1) |
14,816 |
6.1 |
13,078 |
6.2 |
||||
Operating loss |
(18,390) |
(7.6) |
(13,716) |
(6.5) |
||||
Other (expense) income: |
||||||||
Interest expense |
(1,016) |
(0.4) |
(816) |
(0.4) |
||||
Loss on sale of operations, net |
(390) |
(0.2) |
(587) |
(0.3) |
||||
Other income, net (1) (2) |
6,212 |
2.6 |
13,050 |
6.2 |
||||
Total other income, net |
4,806 |
2.0 |
11,647 |
5.5 |
||||
Loss from continuing operations before income tax benefit |
(13,584) |
(5.6) |
(2,069) |
(1.0) |
||||
Income tax benefit |
(3,971) |
(1,979) |
||||||
Loss from continuing operations |
(9,613) |
(4.0) |
(90) |
— |
||||
Loss from operations of discontinued businesses, net of tax |
(7) |
(4) |
||||||
Net loss |
$ (9,620) |
(4.0)% |
$ (94) |
—% |
||||
Diluted loss per share: |
||||||||
Continuing operations |
$ (0.19) |
$ — |
||||||
Discontinued operations |
— |
— |
||||||
Net loss |
$ (0.19) |
$ — |
||||||
Diluted weighted average common shares outstanding |
51,899 |
54,039 |
||||||
Other data from continuing operations: |
||||||||
Adjusted EBITDA (3) |
$ (5,021) |
$ 5,196 |
(1) |
CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and |
Income and expenses related to the deferred compensation plan for the three months ended |
Three Months Ended |
||||||||
2021 |
% of Revenue |
2020 |
% of Revenue |
|||||
Operating expenses |
$ 6,152 |
2.5% |
$ 11,010 |
5.2% |
||||
Corporate general and administrative expenses |
908 |
0.4% |
1,244 |
0.6% |
||||
Other income, net |
7,060 |
2.9% |
12,254 |
5.8% |
Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the three months ended |
Three Months Ended |
|||||||||||||||
2021 |
2020 |
||||||||||||||
As |
Deferred |
Adjusted |
% of |
As |
Deferred |
Adjusted |
% of |
||||||||
Gross margin |
$ (3,574) |
$ 6,152 |
$ 2,578 |
1.1% |
$ (638) |
$ 11,010 |
$ 10,372 |
4.9% |
|||||||
Operating income (expense) |
(18,390) |
7,060 |
(11,330) |
(4.7)% |
(13,716) |
12,254 |
(1,462) |
(0.7)% |
|||||||
Other income (expense), net |
6,212 |
(7,060) |
(848) |
(0.3)% |
13,050 |
(12,254) |
796 |
0.4% |
|||||||
Loss from continuing operations |
(13,584) |
— |
(13,584) |
(5.6)% |
(2,069) |
— |
(2,069) |
(1.0)% |
(2) |
Included in "Other income, net" for the three months ended |
(3) |
Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the most directly comparable GAAP financial measure, and for additional information as to the usefulness of the Non-GAAP financial measures to shareholders and investors. |
FINANCIAL HIGHLIGHTS (UNAUDITED) TWELVE MONTHS ENDED (In thousands, except percentages and per share data)
|
||||||||
Twelve Months Ended |
||||||||
2021 |
% |
2020 |
% |
|||||
Revenue |
|
100.0% |
|
100.0% |
||||
Operating expenses (1) |
945,635 |
85.6 |
825,351 |
85.6 |
||||
Gross margin |
159,290 |
14.4 |
138,546 |
14.4 |
||||
Corporate general and administrative expenses (1) |
56,150 |
5.1 |
46,066 |
4.8 |
||||
Legal settlement, net |
30,468 |
2.7 |
— |
— |
||||
Operating income |
72,672 |
6.6 |
92,480 |
9.6 |
||||
Other income (expense): |
||||||||
Interest expense |
(3,868) |
(0.4) |
(4,983) |
(0.5) |
||||
Gain (loss) on sale of operations, net |
5,995 |
0.5 |
(509) |
(0.1) |
||||
Other income, net (1) (2) |
18,241 |
1.7 |
16,500 |
1.7 |
||||
Total other income, net |
20,368 |
1.8 |
11,008 |
1.1 |
||||
Income from continuing operations before income tax expense |
93,040 |
8.4 |
103,488 |
10.7 |
||||
Income tax expense |
22,129 |
25,141 |
||||||
Income from continuing operations |
70,911 |
6.4 |
78,347 |
8.1 |
||||
Loss from operations of discontinued businesses, net of tax |
(24) |
(48) |
||||||
Net income |
$ 70,887 |
6.4% |
$ 78,299 |
8.1% |
||||
Diluted income per share: |
||||||||
Continuing operations |
$ 1.32 |
$ 1.42 |
||||||
Discontinued operations |
— |
(0.01) |
||||||
Net income |
$ 1.32 |
$ 1.41 |
||||||
Diluted weighted average common shares outstanding |
53,723 |
55,359 |
||||||
Other data from continuing operations: |
||||||||
Adjusted EBITDA (3) |
$ 148,459 |
|
||||||
Adjusted EPS (3) |
$ 1.66 |
$ 1.42 |
(1) |
CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and |
Income and expenses related to the deferred compensation plan for the twelve months ended |
Twelve Months Ended |
||||||||
2021 |
% of Revenue |
2020 |
% of Revenue |
|||||
Operating expenses |
$ 17,317 |
1.6% |
$ 13,806 |
1.4% |
||||
Corporate general and administrative expenses |
2,168 |
0.2% |
1,587 |
0.2% |
||||
Other income, net |
19,485 |
1.8% |
15,393 |
1.6% |
Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the twelve months |
Twelve Months Ended |
|||||||||||||||
2021 |
2020 |
||||||||||||||
As Reported |
Deferred Compensation Plan |
Adjusted |
% of Revenue |
As Reported |
Deferred Compensation Plan |
Adjusted |
% of Revenue |
||||||||
Gross margin |
|
|
|
16.00% |
|
|
|
15.80% |
|||||||
Operating income |
72,672 |
19,485 |
92,157 |
8.30% |
92,480 |
15,393 |
107,873 |
11.20% |
|||||||
Other income (expense), net |
18,241 |
-19,485 |
-1,244 |
-0.10% |
16,500 |
-15,393 |
1,107 |
0.10% |
|||||||
Income from continuing operations before income tax expense |
93,040 |
— |
93,040 |
8.40% |
103,488 |
— |
103,488 |
10.70% |
(2) |
Included in "Other income, net" for the twelve months ended |
(3) |
Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the most directly comparable |
FINANCIAL HIGHLIGHTS (UNAUDITED) (In thousands) SELECT SEGMENT DATA
|
||||||||
Three Months Ended December |
Twelve Months Ended December |
|||||||
2021 |
2020 |
2021 |
2020 |
|||||
Revenue |
||||||||
Financial Services |
$ 156,056 |
$ 131,419 |
734,026 |
629,778 |
||||
Benefits and Insurance Services |
76,667 |
70,325 |
332,323 |
297,758 |
||||
National Practices |
10,105 |
9,366 |
38,576 |
36,361 |
||||
Total |
$ 242,828 |
$ 211,110 |
$ 1,104,925 |
$ 963,897 |
||||
Gross Margin |
||||||||
Financial Services |
(3,338) |
2,147 |
$ 125,788 |
$ 104,569 |
||||
Benefits and Insurance Services |
8,765 |
10,487 |
60,673 |
49,401 |
||||
National Practices |
1,153 |
1,072 |
4,082 |
3,724 |
||||
Operating expenses - unallocated (1): |
||||||||
Other expense |
(4,002) |
(3,334) |
(13,936) |
(5,342) |
||||
Deferred compensation |
(6,152) |
(11,010) |
(17,317) |
(13,806) |
||||
Total |
$ (3,574) |
$ (638) |
$ 159,290 |
$ 138,546 |
(1) |
Represents operating expenses not directly allocated to individual businesses, including stock-based compensation, |
SELECT CASH FLOW DATA (In thousands)
|
||||
Twelve Months Ended |
||||
2021 |
2020 |
|||
Net income |
$ 70,887 |
$ 78,299 |
||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
Depreciation and amortization expense |
27,078 |
23,139 |
||
(Gain) loss on sale of operations, net |
(5,995) |
509 |
||
Bad debt expense, net of recoveries |
3,054 |
4,409 |
||
Adjustments to contingent earnout liability, net |
2,367 |
(629) |
||
Stock-based compensation expense |
11,407 |
8,869 |
||
Other noncash adjustments |
9,108 |
(285) |
||
Net income, after adjustments to reconcile net income to net cash provided by |
117,906 |
114,311 |
||
Changes in assets and liabilities, net of acquisitions and divestitures |
13,272 |
32,605 |
||
Operating cash flows provided by continuing operations |
131,178 |
146,916 |
||
Operating cash used in discontinued operations |
(24) |
(71) |
||
Net cash provided by operating activities |
131,154 |
146,845 |
||
Net cash used in investing activities |
(82,010) |
(46,406) |
||
Net cash used in financing activities |
(69,005) |
(76,609) |
||
Net (decrease) increase in cash, cash equivalents and restricted cash |
(19,861) |
23,830 |
||
Cash, cash equivalents and restricted cash at beginning of year |
$ 170,335 |
$ 146,505 |
||
Cash, cash equivalents and restricted cash at end of period |
$ 150,474 |
$ 170,335 |
||
Reconciliation of cash, cash equivalents and restricted cash to the |
||||
Cash and cash equivalents |
$ 1,997 |
$ 4,652 |
||
Restricted cash |
30,383 |
23,951 |
||
Cash equivalents included in funds held for clients |
118,094 |
141,732 |
||
Total cash, cash equivalents and restricted cash |
$ 150,474 |
$ 170,335 |
SELECT FINANCIAL DATA AND RATIOS (In thousands)
|
||||
|
|
|||
Cash and cash equivalents |
1,997 |
4,652 |
||
Restricted cash |
30,383 |
23,951 |
||
Accounts receivable, net |
242,168 |
216,175 |
||
Current assets before funds held for clients |
293,765 |
268,991 |
||
Funds held for clients |
157,909 |
167,440 |
||
|
840,783 |
756,750 |
||
Total assets |
1,627,934 |
1,513,754 |
||
Current liabilities before client fund obligations |
265,174 |
211,285 |
||
Client fund obligations |
158,115 |
166,989 |
||
Total long-term debt |
154,851 |
107,192 |
||
Total liabilities |
923,386 |
811,134 |
||
|
(694,716) |
(595,297) |
||
Total stockholders' equity |
704,548 |
702,620 |
||
Debt to equity |
22.0% |
15.3% |
||
Days sales outstanding (DSO) - continuing operations (1) |
71 |
72 |
||
Shares outstanding |
52,038 |
54,099 |
||
Basic weighted average common shares outstanding |
52,637 |
54,288 |
||
Diluted weighted average common shares outstanding |
53,723 |
55,359 |
(1) |
DSO is provided for continuing operations and represents accounts receivable, net, at the end of the period, divided by trailing |
GAAP RECONCILIATION (Loss) Income from Continuing Operations to Adjusted EBITDA(1) (In thousands)
|
|||||||
Three Months Ended December |
Twelve Months Ended December |
||||||
2021 |
2020 |
2021 |
2020 |
||||
(Loss) Income from continuing operations |
$ (9,613) |
$ (90) |
$ 70,911 |
$ 78,347 |
|||
Interest expense |
1,016 |
816 |
3,868 |
4,983 |
|||
Income tax (benefit) expense |
(3,971) |
(1,979) |
22,129 |
25,141 |
|||
Loss (gain) on sale of operations, net |
390 |
587 |
(5,995) |
509 |
|||
Legal settlement, net |
— |
— |
30,468 |
— |
|||
Depreciation |
2,771 |
2,516 |
10,781 |
9,568 |
|||
Amortization |
4,386 |
3,346 |
16,297 |
13,571 |
|||
Adjusted EBITDA |
$ (5,021) |
$ 5,196 |
$ 148,459 |
$ 132,119 |
(1) |
CBIZ reports its financial results in accordance with GAAP. This table reconciles Adjusted EBITDA to the most directly |
GAAP RECONCILIATION (Loss) Income and Diluted Earnings Per Share ("EPS") from Continuing Operations to Adjusted (Loss) Income from Continuing Operations and EPS(1) (In thousands)
|
|||||||
Three Months Ended December |
Twelve Months Ended December |
||||||
Amounts |
EPS |
Amounts |
EPS |
||||
(Loss) Income from continuing operations |
$ (9,613) |
$ (0.19) |
$ 70,911 |
$ 1.32 |
|||
Adjustments: |
|||||||
Gain on sale of operations, net |
— |
— |
(6,311) |
(0.12) |
|||
Legal settlement, net |
— |
— |
30,468 |
0.57 |
|||
Income tax effect related to adjustments |
— |
— |
(5,746) |
(0.11) |
|||
Adjusted (loss) income from continuing operations |
$ (9,613) |
$ (0.19) |
$ 89,322 |
$ 1.66 |
(1) |
CBIZ reports its financial results in accordance with GAAP. This table reconciles Adjusted (Loss) Income and Adjusted EPS to the most |
GAAP RECONCILIATION Full Year 2022 EPS from Continuing Operations Guidance to Full Year 2022 Adjusted Diluted EPS (In thousands)
|
|||
Full Year 2022 Guidance |
|||
Low |
High |
||
Diluted EPS - GAAP Guidance |
$ 1.89 |
$ 1.93 |
|
Integration cost related to |
0.10 |
0.10 |
|
Adjusted Diluted EPS Guidance |
$ 1.99 |
$ 2.03 |
|
GAAP Diluted EPS for 2021 |
$ 1.32 |
$ 1.32 |
|
Adjusted Diluted EPS for 2021 |
$ 1.66 |
$ 1.66 |
|
|
43% |
46% |
|
|
20% |
22% |
View original content:https://www.prnewswire.com/news-releases/cbiz-reports-fourth-quarter-and-full-year-2021-results-301484772.html
SOURCE
Ware Grove, Chief Financial Officer -or- Lori Novickis, Director, Corporate Relations, CBIZ, Inc., Cleveland, Ohio, (216) 447-9000